Alzheimer s & Dementia
Method of Research
Subject of Research
Predictive metabolic networks reveal sex and APOE genotype-specific metabolic signatures and drivers for precision medicine in Alzheimer’s Disease
Article Publication Date
RC is the founder of INTelico Therapeutics LLC and co-founder of PATH Biotech LLC. RKD in an inventor on a series of patents on use of metabolomics for the diagnosis and treatment of CNS and other diseases and holds founding equity in Metabolon Inc., Chymia LLC and PsyProtix.